INTELLIA THERAPEUTICS SHARES UP 4.9% PREMARKET AFTER FDA ACCEPTS TO FAST-TRACK CO'S TREATMENT FOR A RARE SWELLING DISORDER

Reuters · 1d ago

Please log in to view news